Clinical Trial Update: Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study) [Phase 2]

View source ↗

Summary

Phase 2 trial update on SPIPROP study for prevention of retinopathy of prematurity; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Retinopathy of Prematurity | Phase 2 | Status: COMPLETED | Results posted: 2020-05-01